Literature DB >> 17879084

Reconstruction of N-acetyltransferase 2 haplotypes using PHASE.

Klaus Golka1, Meinolf Blaszkewicz, Mirabutaleb Samimi, Hermann M Bolt, Silvia Selinski.   

Abstract

The genotyping of N-acetyltransferase 2 (NAT2) by PCR/RFLP methods yields in a considerable percentage ambiguous results. To resolve this methodical problem a statistical approach was applied. PHASE v2.1.1, a statistical program for haplotype reconstruction was used to estimate haplotype pairs from NAT2 genotyping data, obtained by the analysis of seven single nucleotide polymorphisms relevant for Caucasians. In 1,011 out of 2,921 (35%) subjects the haplotype pairs were clearcut by the PCR/RFLP data only. For the majority of the data the applied method resulted in a multiplicity (2-4) of possible haplotype pairs. Haplotype reconstruction using PHASE v2.1.1 cleared this ambiguity in all cases but one, where an alternative haplotype pair was considered with a probability of 0.029. The estimation of the NAT2 haplotype is important because the assignment of the NAT2 alleles *12A, *12B, *12C or *13 to the rapid or slow NAT2 genotype has been discussed controversially. A clear assignment is indispensable in surveys of human bladder cancer caused by aromatic amine exposures. In conclusion, PHASE v2.1.1 software allowed an unambiguous haplotype reconstruction in 2,920 of 2,921 cases (>99.9%).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879084     DOI: 10.1007/s00204-007-0247-9

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  3 in total

1.  Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes.

Authors:  Birte Hellwig; Jan G Hengstler; Marcus Schmidt; Mathias C Gehrmann; Wiebke Schormann; Jörg Rahnenführer
Journal:  BMC Bioinformatics       Date:  2010-05-25       Impact factor: 3.169

2.  Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data.

Authors:  Audrey Sabbagh; Pierre Darlu; Michel Vidaud
Journal:  BMC Med Genet       Date:  2009-12-31       Impact factor: 2.103

3.  Validation of PHASE for deriving N-acetyltransferase 2 haplotypes in the Western Cape mixed ancestry population.

Authors:  Celeste Swart; Surita Meldau; Chad M Centner; Adrian D Marais; Fierdoz Omar
Journal:  Afr J Lab Med       Date:  2020-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.